CinRx
Business Services · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5375 Medpace Way, Cincinnati, Ohio, 4522...Phone Number
(844) 531-1834Website
www.cinrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CinRx
CinRx Pharma is a Cincinnati-based biotech company that employs a unique hub-and-spoke model to identify and accelerate the development of high-impact medicines. The company combines scientific, technical, and clinical expertise with capital to efficiently launch and guide its portfolio of therapeutics through strategic drug development. CinRx has built a differentiated portfolio targeting various conditions, aiming to significantly improve clinical outcomes and quality of life. The team consists of skilled scientists, clinicians, and drug developers committed to advancing impactful medicines.Explore more
CinRx Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CinRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CinRx
Click to see if CinRx had a recent Job posting/layoffs
CinRx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CinRx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CinRx has new funding data
Check out if CinRx is spiking on competitors!
Product Launch: Get notified when CinRx launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CinRx recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined CinRx as Masked Content
Find 3 more new buyers
Compare Similar Companies to CinRx
Compare insights from companies similar to CinRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CinRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CinRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CinRx.
CinRx financials insights
Gather financial insights about CinRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$73M
CinRx Tech Stack
A closer look at the technologies used by CinRx
Most Recent Scoops
Funding
Funding
Project
Spending/Investment
New Hire
Executive Move
Open Position
CinRx News & Media
CinFina Pharma Presents Positive Phase 1 Study Results in Poster Session for CIN-109 and in Late-Breaking Poster for CIN-110, Demonstrating the Potential of Next-Generation Mechanisms at ObesityWeek® 2024
CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline interim data from its Phase 1 single ascending dose (SAD) study of CIN-110 and final data from its multiple ascending dose (MAD) study of CIN-109, with both programs demonstrating tolerability and meaningful weight loss. CIN-110 is a novel, long-acting PYY3-36 analog designed to significantly reduce gastrointestinal (GI)CinFina Pharma to Present Posters Demonstrating the Potential of New Mechanisms at ObesityWeek® 2024
CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, will present two posters at ObesityWeek® 2024, held at the Henry B. Gonzalez Convention Center in San Antonio from November 2nd to 6th. Poster Presentations: Title: Safety, Pharmacokinetics, and Effect of Novel PYY Analog CIN-110 on Weight in Subjects with Obesity Date: Tuesday, November 5, 2024 Time: 2:30 – 3:30pm CST Location: Exhibit Hall 4BCinFina Pharma Announces Initiation of Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of CIN-110 for the Treatment of Obesity
CINCINNATI--(BUSINESS WIRE)--CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity and metabolic diseases, today announced the initiation of the Phase 1 MAD clinical trial for CIN-110, a novel, highly selective PYY3-36 analog for the treatment of obesity. This Phase 1 MAD clinical trial aims to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of CIN-110 in adults with obesity. The initiatCinRx Pharma Announces Additional $73 Million Financing
CINCINNATI--(BUSINESS WIRE)--CinRx Pharma, a hub-and-spoke biotech accelerating high-impact medicines, today announced the closing of a $73 million financing, bringing the total funds raised to $176 million. Participants in the round include prior investors comprised of industry insiders and high-net-worth individuals. To date, CinRx has launched five companies (“CinCos”) focused primarily on cardiovascular, metabolic and gastrointestinal conditions. In addition to its company creation function
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CinRx
Sign Up For FreeTo access detailed company insights
CinRx Pharma is a Cincinnati-based biotech company that employs a unique hub-and-spoke model to identify and accelerate the development of high-impact medicines. The company combines scientific, technical, and clinical expertise with capital to efficiently launch and guide its portfolio of therapeutics through strategic drug development. CinRx has... Read More
